Canada markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.23+0.62 (+11.05%)
At close: 04:00PM EDT
6.09 -0.14 (-2.25%)
After hours: 07:50PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 86.06M
Enterprise Value 30.60M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.89
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.21

Trading Information

Stock Price History

Beta (5Y Monthly) 1.65
52-Week Change 315.58%
S&P500 52-Week Change 3-8.83%
52 Week High 312.47
52 Week Low 34.06
50-Day Moving Average 35.94
200-Day Moving Average 37.80

Share Statistics

Avg Vol (3 month) 3875.26k
Avg Vol (10 day) 3663.99k
Shares Outstanding 515.52M
Implied Shares Outstanding 6N/A
Float 812.75M
% Held by Insiders 125.39%
% Held by Institutions 121.61%
Shares Short (May 30, 2022) 41.69M
Short Ratio (May 30, 2022) 44.57
Short % of Float (May 30, 2022) 4N/A
Short % of Shares Outstanding (May 30, 2022) 411.08%
Shares Short (prior month Apr 28, 2022) 41.87M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:300
Last Split Date 3Jan 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2021
Most Recent Quarter (mrq)Apr 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-23.47%
Return on Equity (ttm)-46.36%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.64M
Net Income Avi to Common (ttm)-13.81M
Diluted EPS (ttm)-0.95
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.53M
Total Cash Per Share (mrq)2.87
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)126.20
Book Value Per Share (mrq)2.95

Cash Flow Statement

Operating Cash Flow (ttm)-11.1M
Levered Free Cash Flow (ttm)-5.51M